Medi Caps Q2 FY27 Results: Net Loss of ₹0.1 Cr, Loss Narrows
Medi Caps Ltd reported revenue from operations of ₹5.8 Cr (+190.0% YoY) and a net loss of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.1 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
18 announcements with these filters
Medi Caps Ltd reported revenue from operations of ₹5.8 Cr (+190.0% YoY) and a net loss of ₹0.1 Cr for Q2 FY27.
Medi-Caps Ltd intimated its Board meeting is scheduled for 04 November 2026 to consider Q1 and H1 FY27 financial results. No decisions have been taken yet.
The company submitted its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Medi-Caps Limited has re-appointed Alok K Garg as Executive Director and appointed Saloni Garg as an additional Executive Director for a 36-month term.
Medi-Caps Limited held its 43rd Annual General Meeting on September 22, 2026. The meeting proceedings covered financial adoption and director appointments.
Medi-Caps Limited is notifying shareholders without registered email addresses about the 43rd AGM and Annual Report availability. The documents are accessible via the provided web links.
Medi-Caps Limited has submitted its Integrated Annual Report for the financial year 2025-26. The 43rd Annual General Meeting is scheduled for September 22, 2026.
Medi-Caps Limited has issued the notice for its 43rd Annual General Meeting scheduled for September 22, 2026. The meeting will address financial statements and director re-appointments.
Medi-Caps Limited announced the resignations of its CFO and Chairperson, and appointed Akshit Garg as the new Chief Financial Officer.
Medi Caps Ltd reported revenue from operations of ₹2.8 Cr (+3.7% YoY) and a net loss of ₹2.2 Cr for Q1 FY27.
Mr. Ramesh Chandra Mittal and Mrs. Kusum Mittal have resigned as Directors of Medi Caps Ltd effective August 6, 2026, citing personal health concerns.
Medi Caps Ltd scheduled a Board Meeting for August 6, 2026. The board will consider the un-audited financial results for the quarter ended June 30, 2026.
Medi-Caps Limited announced the resignation of Chief Financial Officer Hemant Sethi, effective June 6, 2026. The departure follows his decision to pursue external professional opportunities.
Medi-Caps Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms adherence to SEBI regulations and listing requirements.
Medi-Caps Limited re-appointed Praveen Shrivastava & Company as Internal Auditor for FY 2026-27. The move ensures continued statutory compliance and strengthens internal audit controls.
Medi Caps Ltd reported revenue from operations of ₹3.4 Cr (-51.4% YoY) and net profit of ₹3 Cr (+76.5% YoY) for Q4 FY26.
Medi-Caps Limited reported its audited FY26 financial results, showing a standalone loss of ₹13.87 Lacs. Auditors issued an unmodified opinion for the consolidated and standalone accounts.
Medi-Caps Limited scheduled a board meeting on May 21, 2026, to approve audited financial results. The trading window remains closed for designated insiders until results declaration.